Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Apr 21:15:171.
doi: 10.1186/s12913-015-0791-6.

Randomised evaluation of the Italian medicines use review provided by community pharmacists using asthma as a model (RE I-MUR)

Andrea Manfrin  1 , Trudy Thomas  2 , Janet Krska  3
Affiliations
Randomized Controlled Trial

Randomised evaluation of the Italian medicines use review provided by community pharmacists using asthma as a model (RE I-MUR)

Andrea Manfrin et al. BMC Health Serv Res. .

Abstract

Background: The Italian Ministry of Health decided to introduce community professional services in 2010. This trial provides an opportunity to evaluate the outcomes of a new professional pharmacy service: Italian Medicines Use Review (I-MUR) aimed at reducing the severity of asthma and its associated costs.

Methods/design: This is a cluster randomised controlled trial of the I-MUR service. Data will be collected over time before, during and after pharmacists' intervention. Fifteen Italian regions will be involved and it is aimed to recruit 360 community pharmacists and 1800 patients. Each pharmacist will receive training in medicines use review, recruit five patients, administer the Asthma Control Test and provide the I-MUR service. Pharmacists will be allocated to different groups, one group will be trained in and provide the I-MUR service immediately after completion of the baseline ACT score, the other group will receive training in the I-MUR and provide this service three months later. Group allocation will be random, after stratification by region of Italy. The I-MUR service will involve gathering data following each patient consultation including demographic details, patients regular medications, including those used for asthma, their attitude towards their medications and self-reported adherence to treatments. In addition, pharmacists will identify and record pharmaceutical care issues and any advice given to patients during the I-MUR, or recommendations given to doctors. Pharmacists will upload trial data onto a web platform for analysis. The primary outcome measure is the severity of asthma before, during and after the I-MUR assessed using the Asthma Control Test score. Secondary measures: number of all active ingredients used by patients during and after the I-MUR, number of pharmaceutical care issues identified during the I-MUR, patients' self-reported adherence to asthma medication during and after the I-MUR, healthcare costs based on the severity of asthma, before, during and after the I-MUR service provision.

Discussion: This study has been developed because of the need for a new way of working for pharmacists and pharmacies; it is the first trial of any community pharmacy-based pharmaceutical care intervention in Italy. The results will inform future policy and practice in Italian community pharmacy.

Trial registration number: ISRCTN72438848 .

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram for the study (Adapted from BMJ 2012; 345:e5661 doi:10.1136/Bmj.e5661, September 2012).
Figure 2
Figure 2
Study timeline, showing activities provided by pharmacists and information gathered.
See this image and copyright information in PMC

References

    1. GINA. Global Burden of Asthma 2003. http://ginasthma.org/local/uploads/files/GINABurdenSummary_1.pdf. Accessed 15 Nov 2013.
    1. European Lung White Book. The burden of lung disease. European Respiratory Society. http://www.erswhitebook.org/chapters/adult-asthma/. Accessed 24 Jun 2014.
    1. European Lung White book. The economic burden of lung disease. European Respiratory Society. http://www.erswhitebook.org/chapters/the-economic-burden-of-lung-disease/. Accessed 24 Jun 2014.
    1. Godard P, Chanez P, Siraudinn L, Nicoloyannis DG. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J. 2002;19:61–7. doi: 10.1183/09031936.02.00232001. - DOI - PubMed
    1. Antonicelli L, Bucca C, Neri M, De Benedetto F, Sabbatani P, Bonifazi F, et al. Asthma severity and medical resource utilization. Eur Res J. 2004;23:723–9. doi: 10.1183/09031936.04.00004904. - DOI - PubMed

Publication types

Substances

Associated data